Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-08

Clinical Trial Update: Malignant Pleural Effusion: Pleur-X vs. Chemical Pleurodesis in VATS [NA]

View source ↗

Summary

Clinical trial update comparing PleurX catheter use versus chemical pleurodesis performed via VATS for malignant pleural effusion; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemical Pleurodesis (agent unspecified) (chemical pleurodesis agent)
  • PleurX catheter

Snippet

Sponsor: Rolf Inderbitzi | Conditions: Malignant Pleural Effusion | NA | Status: UNKNOWN